Your email has been successfully added to our mailing list.

×
-0.000283446712018084 -0.00226615646258494 -0.010204081632653 -0.00722789115646266 -0.0046768707482993 0.0150226757369615 -0.00382653061224484 -0.0127551020408164
Stock impact report

Gilead asks FDA to revoke orphan drug status for potential coronavirus drug [Reuters]

Gilead Sciences, Inc. (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Company Research Source: Reuters
Gilead asks FDA to revoke orphan drug status for potential coronavirus drug March 25 (Reuters) - Gilead Sciences Inc said on Wednesday it had requested the U.S. Food and Drug administration to rescind the “orphan drug” status for its experimental drug, remdesivir, seen as one of the more promising potential treatments for the coronavirus. The drugmaker said it was confident of maintaining an expedited timeline for seeking regulatory review of remdesivir, without the orphan drug designation. The orphan drug status provides a seven-year market exclusivity period, as well as tax and other incentives for drug companies developing treatments for rare diseases that affect fewer than 200,000 people. (Reporting by Manas Mishra in Bengaluru; Editing by Vinay Dwivedi) Show less Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GILD alerts
Opt-in for
GILD alerts

from News Quantified
Opt-in for
GILD alerts

from News Quantified